The Food and Drug Administration (FDA) is announcing the renewal of the National Mammography Quality Assurance Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the National Mammography Quality Assurance Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until July 6, 2017.
Document
National Mammography Quality Assurance Advisory Committee, Renewal
The Food and Drug Administration (FDA) is announcing the renewal of the National Mammography Quality Assurance Advisory Committee by the Commissioner of Food and Drugs (the Comm...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 48867
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“National Mammography Quality Assurance Advisory Committee, Renewal,” thefederalregister.org (August 14, 2015), https://thefederalregister.org/documents/2015-20050/national-mammography-quality-assurance-advisory-committee-renewal.